8
How to Invest in Marijuana: Cannabis Stocks Explained
Marijuana is big business.
The once-shadowy industry has transformed into a highly commercialized and profitable sector, spanning biotech and research companies, as well as marijuana growers and consumer retailers.
More than 440,000 full-time jobs were supported by the legal cannabis industry in 2024, according to a report by Flowhub.
By 2030, the U.S. legal marijuana market is expected to reach $40 billion, according to a report by Grand View Research.
Buying into an emerging industry poised for moonshot growth is enough to make any investor’s mouth water.
But the cannabis business isn’t like other cash crops. It’s still illegal at the federal level, which can make investing in cannabis stocks tricky.
Marijuana investments involve risk — but is the potential upshot worth it?
In this guide, we’ll explore the different types of marijuana companies, pros and cons of investing in the industry, top cannabis stocks and more.
States began legalizing medical marijuana more than 20 years ago. By late 2023, 40 states plus the District of Columbia permitted the sale of medical weed.
Recreational use also is booming. In 2012, Colorado and Washington became the first states to legalize recreational marijuana for adult use. More than a decade later in 2023, 24 states plus D.C. permitted recreational use, further expanding the legal cannabis industry.
In 2018, the production of hemp and, by extension, CBD oil was legalized at the national level. (The U.S. government defines hemp as any cannabis plant containing less than 0.3% of THC, the psychoactive substance that gets users high.)
But progress to legalize marijuana at the federal level remains mixed.
In October 2022, President Joe Biden granted clemency to certain low-level federal marijuana offenders and directed the attorney general to review the status of marijuana under federal law.
The U.S. Department of Health and Human Services also recently recommended reclassifying marijuana as a lower-risk drug.
Marijuana is currently a Schedule I drug under the Controlled Substances Act. Schedule I drugs are defined as having no currently accepted medical use in the U.S. and a high potential for abuse.
The HHS has reportedly called for pot to be reclassified as a Schedule III drug, meaning it has moderate to low potential for physical or psychological dependence.
The Drug Enforcement Administration, which has final authority on reclassifying marijuana, will review the recommendation.
A reclassification could majorly expand the pot market.
Still, recent rumblings in Washington, D.C., aren’t likely to result in full federal legalization anytime soon, forcing many cannabis companies and retail investors to linger in legal limbo.
Cannabis may be booming, but there are still only a few dozen publicly traded companies.
Because Canada became the first G20 country to legalize recreational weed in 2018, many marijuana stocks are headquartered there. U.S. companies that directly handle marijuana are barred from listing on U.S. stock exchanges.
Before you invest in marijuana, it’s important to understand different aspects of the industry.
First, there are two broad categories of cannabis products.
Medical cannabis, which is grown and used to treat various medical conditions such as chronic pain, is legal in 40 U.S. states and the District of Columbia. It’s also legal in more than 30 countries. A patient needs a prescription from an authorized health care provider to obtain medical marijuana.
Twenty-four U.S. states, plus the District of Columbia, have legalized recreational marijuana for adults. Recreational use also is legal in several countries, including Canada, Mexico and South Africa. Because states have been slower to adopt recreational marijuana laws, the recreational sector accounts for a much smaller share of revenue within the legal cannabis market.
Numerous products are made from cannabis plants, including marijuana flower, CBD oils, edibles and hemp, as well as concentrates used in vaping and other items.
The marijuana industry supply chain is extensive, spanning manufacturing to marketing.
Cannabis growers cultivate the plant. Some also own production facilities or create cannabis-related products, like hemp.
These companies own dispensaries where people can purchase cannabis products.
These pharmaceutical companies develop prescription drugs with cannabis ingredients.
These companies facilitate the legal marijuana industry with services like distribution, marketing, hydroponic technologies, lighting systems and packaging.
Because the drug is still federally illegal, investing in U.S. cannabis stocks can be tricky. Buying shares of cannabis-related companies is one option.
Ancillary firms are listed on U.S. stock exchanges because these publicly traded companies don’t deal with the plant itself.
For example, Innovative Industrial Properties (IIPR) is an industrial real estate investment trust that specializes in leasing property to cannabis growers and other companies in the medical marijuana market.
The marijuana industry is ripe for growth, but plenty of roadblocks remain, especially for U.S. companies and investors.
Before you jump into the cannabis industry, it’s important to understand what makes these stocks so exciting — and so risky.
Marijuana is a nascent industry. Getting in on the ground floor is one of the biggest potential rewards for marijuana investors.
By getting in early, you might be able to capture larger-than-average returns as the cannabis industry expands and evolves.
Legal cannabis sales are expected to top $53.5 billion by 2027, according to a study by MJBiz, a leading B2B cannabis company.
With a majority of Americans in favor of legalizing marijuana, industry supporters say it’s only a matter of time before the U.S. government gives weed the green light.
People looking to invest in cannabis could buy cheap shares during the current market lull and hold their stocks until prices rise.
Some investors may see this as a prime buying opportunity. Once the federal government legalizes weed, institutional investors are likely to pour money into the marijuana industry and send cannabis stock prices soaring.
Marijuana stocks aren’t a good fit for conservative investors who hate the idea of losing money. But if you can stomach risk, devote time to researching companies and hold these assets for a few years, marijuana investing may be a good pick for your portfolio.
Investing involves risk. An asset can lose value as market conditions change. This holds true for any industry — not just marijuana companies.
But pot stocks can be particularly volatile.
Yes, weed is still illegal at the national level, but it’s more than that.
Investing in cannabis stocks is risky because:
Like any budding market, the cannabis industry has seen its share of bad actors. Companies poised for tremendous growth potential can suddenly underperform, get acquired by another company or even go bankrupt.
The U.S. Securities and Exchange Commission has issued several alerts over the years regarding marijuana stocks, warning consumers about unlicensed sellers, unsolicited offers, market manipulation and fake news releases meant to influence share prices.
In short, taking a chance on inexperienced and obscure companies can devastate your investment returns.
Another risk is investing in companies that exist simply because marijuana is still prohibited under federal law. Businesses that cropped up to solve a problem — like alternative banking systems for marijuana dispensaries — could suddenly disappear once national legalization occurs.
We’ll discuss ways to mitigate risks associated with cannabis investing when we delve further into how to invest in marijuana.
Below is a list of the top marijuana stocks to consider. Our list only includes companies with market caps of at least $200 million with figures current as of May 2024.
10 Marijuana Stocks to Consider
Below is a list of the top marijuana stocks to consider. Our list only includes companies with market caps of at least $200 million with figures current as of September 2023.
Follow these steps when investing in marijuana stocks:
Marijuana’s illegal status at the federal level makes it harder for U.S. companies to get listed on a mainstream stock exchange.
Typically, shares of Canadian companies are the easiest pot stocks to buy in the U.S. So long as Canadian companies don’t sell marijuana in America, they can be listed on the Nasdaq or New York Stock Exchange.
But experts are mixed about the growth potential of Canada’s publicly traded cannabis companies.
In 2018, our neighbors to the north legalized recreational marijuana, spurring a boom of global investment. Stock prices soared, crashed, soared and crashed again.
Canadian marijuana stocks had a brutal 2021 and 2022, with share prices for companies like Cronos Group down by double digits.
Experts say overexpansion is to blame. In short, the Candianan industry burned through too much money, grew too much weed and rolled out retail dispensaries too slowly.
The result: Canadian cannabis companies are struggling to turn a profit, leading some investment experts to suggest the biggest areas of growth lie in the U.S. cannabis market.
The United States has a much larger and more lucrative marijuana market than Canada. But American-based cannabis businesses can’t list on U.S. stock exchanges.
This leaves U.S. cannabis companies two options: Get listed on a Canadian exchange or trade over the counter.
Stocks purchased on over-the-counter exchanges are very speculative because they aren’t required to disclose certain financial information to the public, making it nearly impossible to conduct a true analysis of a stock’s value.
It’s also tricky for the average investor to even buy and sell OTC stocks. Many traditional brokerage accounts restrict or bar trading marijuana stocks on OTC exchanges.
You may need to use a special brokerage account to purchase shares of U.S. marijuana companies, although a few well-known discount brokers carry OTC stocks, including Fidelity and TD Ameritrade. Charles Schwab also lets you buy your own over-the-counter shares using the Schwab One brokerage account.
However, be cautious of trading fees. Some online brokerage firms charge a fee or trading commission on these stocks — even if the investment platform offers free trades on other securities.
There are two primary ways to invest in marijuana: individual stocks and exchange-traded funds (ETFs).
ETFs are typically a good way to diversify your portfolio because they spread your investment dollars among several companies at once.
Marijuana ETFs can be less risky than investing in an individual marijuana stock because ETFs diversify you across every vertical of the cannabis industry, from product conception to consumption.
It may also be easier for the average investor to buy a marijuana ETF because several are listed on U.S. exchanges.
Going with an actively managed ETF, like Amplify Seymour Cannabis (CNBS) or AdvisorShares Pure US Cannabis (MSOS), is probably your best bet.
Actively managed funds are more responsive to industry shake-ups, like mergers, acquisitions and bankruptcies. Portfolio managers of actively managed ETFs are more nimble, allowing them to take advantage of dips in stock prices and divest from problematic companies.
In contrast, passively managed ETFs, like Horizons US Marijuana Index (HMUS) and the Cannabis ETF (THCX), are rebalanced and tweaked only once a quarter. A lot can happen in three months, especially in this industry.
If you’re trying to find the best marijuana ETF to buy, peek under the hood and look at the specific stocks a fund owns. Also make sure to examine the fund’s recent price movements along with its one-year and five-year returns.
The best marijuana companies share a few similarities. Here’s what to look for when picking cannabis investments that can help you mitigate (some) of the industry’s inherently risky nature.
Rachel Christian is a Certified Educator in Personal Finance and a senior writer at The Penny Hoarder. She focuses on investing, retirement, taxes and life insurance.
This article contains general information and explains options you may have, but it is not intended to be investment advice or a personal recommendation. We can't personalize articles for our readers, so your situation may vary from the one discussed here. Please seek a licensed professional for tax advice, legal advice, financial planning advice or investment advice.
Ready to stop worrying about money?
Get the Penny Hoarder Daily
Some of the links in this post are from our sponsors. We strive to provide accurate, reliable information.
Compensation may influence how and where products appear on our site (including their order), and we do not include all companies or offers.